September 9, 2021
Researchers from The University of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.
August 16, 2021
Currently, the CDC is recommending the third dose for only moderately to severely immunocompromised persons.
August 10, 2021
As children return to area schools this month, here are some points of interest about the delta COVID variant from experts at UT Health San Antonio.
August 2, 2021
In a sample of more than 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment.
July 27, 2021
Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.
July 20, 2021
We at UT Health San Antonio are closely monitoring the recent increase in community prevalence and transmission of the COVID-19 virus. At present, elsewhere and here in San Antonio, the latest surge is predominantly related to spread by the COVID delta variant. The delta variant is about four times more contagious than the original alpha variant and two times more lethal for unvaccinated people. Given the marked increase in community prevalence and spread, it is prudent that we increase our preventive protocols so that we can continue to keep on-campus transmission rates low.